1. Home
  2. NX vs INBX Comparison

NX vs INBX Comparison

Compare NX & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$18.57

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$102.50

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
INBX
Founded
1927
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
999.7M
IPO Year
2008
2024

Fundamental Metrics

Financial Performance
Metric
NX
INBX
Price
$18.57
$102.50
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$28.00
$150.00
AVG Volume (30 Days)
286.5K
442.3K
Earning Date
06-04-2026
05-15-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$1,300,000.00
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.81
550.00
52 Week Low
$11.04
$12.80
52 Week High
$22.90
$155.29

Technical Indicators

Market Signals
Indicator
NX
INBX
Relative Strength Index (RSI) 49.34 45.50
Support Level $18.30 $99.20
Resistance Level $20.24 $153.14
Average True Range (ATR) 0.74 11.61
MACD 0.06 -3.13
Stochastic Oscillator 61.78 7.41

Price Performance

Historical Comparison
NX
INBX

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: